Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-23-000031

Director sold 2,119 shares at $30.10 ($63,782)

From the SEC's structured data for this filing

Trades in this filing

Krognes Steve E. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-02-13 Sale : show line 1 in the form −2,119 $30.10 $63,782 143,002 D
Open-market sales · 2,119 sh · avg $30.10 · $63,782
Loading xslF345X03/wf-form4_167650571634751.xml…